Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Sitagliptin 100mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement
Current Medical Research and Opinion, 10/08/09
Alba M et al. – Across sitagliptin doses in this study, the similarity of the 24–h WMG concentrations and the similarity of the corrected DPP–4 inhibition values support prior findings that the maximal glucose–lowering efficacy of sitagliptin is achieved with once–daily dosing of 100mg.
Related Articles
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation
Journal of Diabetes and its Complications, 10/29/09
Relevance Score: 85%
Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 82%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Impaired fasting glucose as a treatment target in diabetes management
Current Cardiology Reports, 12/09/09
Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS)
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/09/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC–FFCD 9710
Endocrine-Related Cancer, 12/09/09
A Randomized Controlled Trial of Oxycodone vs Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin
The Journal of Pain, 12/09/09
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


